# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Probenecid | probenecid | Ki | = | 766 | uM | ALA2077537 | inhibitor [Ki=766uM] | nM | Homo sapiens | ||
2. | Betamipron | SID26746918 | Activity | 0 | ALA2077537 | is not an inhibitor [-] | Homo sapiens | |||||
3. | Cilastatin | 174 | Activity | 0 | ALA2077537 | is not an inhibitor [-] | Homo sapiens | |||||
4. | KW 3902 | 2 (KW-3902) | Activity | 0 | ALA2077537 | is not an inhibitor [-] | Homo sapiens | |||||
5. | α-Ketoglutaric acid | alpha-ketoglutarate | Activity | 0 | ALA2075465 | is not an inhibitor [-] | Homo sapiens | |||||
6. | Probenecid | probenecid | IC50 | = | 668 | uM | ALA2077493 | inhibitor [IC50=668 +/- 206uM] | nM | Homo sapiens | ||
7. | Pravastatin | 2 (pravastatin) | IC50 | = | 352 | uM | ALA2077493 | inhibitor [IC50=352 +/- 153uM] | nM | Homo sapiens | ||
8. | ALA1440 | Tetracycline | Km | = | 439.9 | uM | ALA2077617 | substrate [Km=439.9uM] | nM | Homo sapiens | ||
9. | Cefotaxime acid | cefotaxime | IC50 | = | 4.68 | mM | ALA2077074 | inhibitor [IC504.68mM] | nM | Homo sapiens | ||
10. | cefaloridine | cephaloridine | IC50 | = | 4.48 | mM | ALA2077074 | inhibitor [IC504.48mM] | nM | Homo sapiens | ||
11. | cefamandole | cefamandol | IC50 | = | 1.57 | mM | ALA2077074 | inhibitor [IC501.57mM] | nM | Homo sapiens | ||
12. | Cephalothin | Cephalothin | IC50 | = | 1.41 | mM | ALA2077074 | inhibitor [IC501.41mM] | nM | Homo sapiens | ||
13. | Cefoperazone | Cefoperazone | IC50 | = | 1.33 | mM | ALA2077074 | inhibitor [IC501.33mM] | nM | Homo sapiens | ||
14. | 3′-Azido-3′-deoxythymidine | AZT | Km | = | 26.8 | uM | ALA2077616 | substrate [Km=26.8uM] | nM | Homo sapiens | ||
15. | 3′-Azido-3′-deoxythymidine | AZT | Activity | = | 76.7 | % | ALA2075464 | inhibitor [76.7 % of control] | % | Homo sapiens | ||
16. | Ganciclovir | Ganciclovir | Activity | = | 63.3 | % | ALA2075463 | inhibitor [63.3 % of control] | % | Homo sapiens | ||
17. | Prostaglandin E₂ | PGE2 | Activity | = | 21.2 | % | ALA2075459 | inhibitor [21.2 % of control] | % | Homo sapiens | ||
18. | Theophylline | 22 | Activity | 0 | ALA2077490 | substrate [] | Homo sapiens | |||||
19. | erythromycin | Ery | Activity | 0 | ALA2077490 | substrate [] | Homo sapiens | |||||
20. | erythromycin | Ery | Activity | 0 | ALA2077492 | inhibitor [] | Homo sapiens |